Free Trial
OTCMKTS:SHPMF

Shanghai Pharmaceuticals (SHPMF) Stock Price, News & Analysis

$1.57 0.00 (0.00%)
As of 03/13/2025

About Shanghai Pharmaceuticals Stock (OTCMKTS:SHPMF)

Key Stats

Today's Range
$1.57
$1.57
50-Day Range
$1.18
$1.62
52-Week Range
$0.99
$1.95
Volume
N/A
Average Volume
39,520 shs
Market Capitalization
N/A
P/E Ratio
1.68
Dividend Yield
16.78%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.

Remove Ads

Shanghai Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

SHPMF MarketRank™: 

Shanghai Pharmaceuticals scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Shanghai Pharmaceuticals.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Shanghai Pharmaceuticals is 1.68, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.47.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Shanghai Pharmaceuticals is 1.68, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.66.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Shanghai Pharmaceuticals has a short interest ratio ("days to cover") of 60.6, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Shanghai Pharmaceuticals has recently decreased by 44.03%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Shanghai Pharmaceuticals pays a meaningful dividend of 2.01%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Shanghai Pharmaceuticals does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Shanghai Pharmaceuticals is 28.26%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Shanghai Pharmaceuticals' dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Shanghai Pharmaceuticals has a short interest ratio ("days to cover") of 60.6, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Shanghai Pharmaceuticals has recently decreased by 44.03%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Shanghai Pharmaceuticals has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Shanghai Pharmaceuticals this week, compared to 0 articles on an average week.
Receive SHPMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shanghai Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SHPMF Stock News Headlines

Musk’s real agenda in D.C.
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…
See More Headlines

SHPMF Stock Analysis - Frequently Asked Questions

Shanghai Pharmaceuticals' stock was trading at $1.64 at the start of the year. Since then, SHPMF stock has decreased by 4.3% and is now trading at $1.57.
View the best growth stocks for 2025 here
.

Shares of SHPMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Distribution
Sub-Industry
N/A
Current Symbol
OTCMKTS:SHPMF
Fax
N/A
Employees
49,234
Year Founded
N/A

Profitability

Trailing P/E Ratio
1.68
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:SHPMF) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners